BRÈVE publiée le 10/12/2025 à 10:10, il y a 10 mois 30 jours NTC Acquires Pharmathen's Ophthalmology Business International Expansion Ophthalmology NTC Acquisition Wise Equity Support Glaucoma Treatments
BRÈVE publiée le 10/12/2025 à 10:10, il y a 10 mois 30 jours NTC acquiert l'activité ophtalmologique de Pharmathen Expansion Internationale Ophtalmologie Acquisition De NTC Soutien Wise Equity Traitements Du Glaucome
COMMUNIQUÉ DE PRESSE publié le 10/12/2025 à 10:05, il y a 10 mois 30 jours NTC, BACKED BY WISE EQUITY, COMPLETES THE ACQUISITION OF PHARMATHEN'S OPHTHALMOLOGY BUSINESS NTC, backed by Wise Equity, completes the acquisition of Pharmathen's ophthalmology business, expanding their glaucoma portfolio and international presence Acquisition Glaucoma Ophthalmology NTC Wise Equity
Publié le 09/11/2026 à 10:32, il y a 4 heures 32 minutes Disclosure of shares outstanding and voting rights - 09.11.2026
Publié le 09/11/2026 à 10:32, il y a 4 heures 32 minutes Déclaration nombre d'actions et droits de vote - 09.11.2026
Publié le 09/11/2026 à 07:00, il y a 8 heures 4 minutes bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Publié le 09/11/2026 à 07:00, il y a 8 heures 4 minutes BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Publié le 09/11/2026 à 14:15, il y a 49 minutes Jericho Energy Ventures to Participate in Cantor Convergence 4th Annual Crypto and AI Infrastructure Conference
Publié le 09/11/2026 à 14:00, il y a 1 heure 4 minutes Tectonic Metals Adds Mine Development and Alaska Native Partnership Leaders Ahead of 2027 Mineral Resource Estimate and Preliminary Economic Assessment
Publié le 09/11/2026 à 14:54, il y a 10 minutes Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Publié le 09/11/2026 à 14:54, il y a 10 minutes Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
